Correlation Between Regeneron Pharmaceuticals and SIMON

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and SIMON at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and SIMON into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and SIMON PROPERTY GROUP, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and SIMON and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of SIMON. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and SIMON.

Diversification Opportunities for Regeneron Pharmaceuticals and SIMON

0.36

Correlation Coefficient

Regeneron Pharmaceuticals  SIMON

Weak diversification

The 3 months correlation between Regeneron and SIMON is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and SIMON PROPERTY GROUP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIMON PROPERTY GROUP and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with SIMON. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIMON PROPERTY GROUP has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and SIMON go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and SIMON

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 2.18 times more return on investment than SIMON. However, Regeneron Pharmaceuticals is 2.18 times more volatile than SIMON PROPERTY GROUP. It trades about 0.01 of its potential returns per unit of risk. SIMON PROPERTY GROUP is currently generating about 0.02 per unit of risk. If you would invest  71,557  in Regeneron Pharmaceuticals on October 10, 2024 and sell it today you would earn a total of  1,473  from holding Regeneron Pharmaceuticals or generate 2.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.19%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  SIMON PROPERTY GROUP

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

SIMON PROPERTY GROUP

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SIMON PROPERTY GROUP are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, SIMON is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Regeneron Pharmaceuticals and SIMON

The main advantage of trading using opposite Regeneron Pharmaceuticals and SIMON positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, SIMON can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIMON will offset losses from the drop in SIMON's long position.

The idea behind Regeneron Pharmaceuticals and SIMON PROPERTY GROUP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.